ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) approval of an innovative insulation material for cardiac leads used with pacemakers and implantable cardioverter defibrillators (ICDs). Optim™ lead insulation is the first silicone-polyurethane co-polymer material created specifically for cardiac lead use.
